Skip to main content
08/05/2017 - 06:31

PharmAust secures anti-cancer drug patent in China

08/05/2017 - 06:31

Bookmark

Save articles for future reference.

ASX listed PharmAust has taken a major step towards safeguarding the intellectual property of its promising anti-cancer drug after being granted a key patent in China. The patent strengthens the Perth-based company’s IP protection in a critical world market and provides protection for 16 years, with PharmAust expecting further patents to be issued in coming months.

X